ProPhase Labs to effect 1-for-10 reverse stock split to maintain Nasdaq listing

ProPhase Labs, Inc.

Stockholders approved reverse stock split on Nov 24, 2025; board approved Nov 30, 2025.
Certificate of Amendment filed Dec 2, 2025; split effective Dec 22, 2025 at 8:00 AM ET.
After split, approximately 5,768,951 shares of common stock will be outstanding.
No fractional shares; any fractional shares rounded up to whole share.
Reverse split intended to increase per-share price to meet Nasdaq continued listing requirements.

item 5.03item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.